Yüklüyor......
Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
BACKGROUND: There is no standard therapy for second-line treatment of gemcitabine-refractory pancreatic cancer patients with poor performance status. A combination of chemotherapy drugs 5-fluorouracil (5-FU), leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) or 5-fluorouracil/leucovorin plus nano...
Kaydedildi:
| Yayımlandı: | World J Gastrointest Oncol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6883178/ https://ncbi.nlm.nih.gov/pubmed/31798782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v11.i11.1021 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|